Antineoplastic agents such as immunotherapies and targeted therapies that specifically target signaling pathways in cancer cells are associated with thyroid dysfunction in 20%-50% of cancer patients taking them, which can adversely affect patients' quality of life, according to a study published Oct. 18 in the Journal of the National Cancer Institute.
50977
Antineoplastic agents associated with thyroid dysfunction
83482
Breast cancer pain related to fatigue
150879
Many cancer survivors have poor health habits
40508
The ovarian cancer drug market will more than triple over the next decade, increasing from $460 million in 2011 to $1.4 billion in 2021
119354
Hip replacement patients could face increased risk of cancer:
9895
New compounds kill ovarian, testicular, head and neck cancer cells with less toxicity
160568
Antidepressants may help fight cancer
139610
Many cancers diagnosed late, making treatment difficult
147036
Ipilimumab works to stimulate the body's own immune system to fight prostate cancer
76381
HRT improves quality of life
43164
Transplant patients experience worse outcomes from cancer
172283
Cancer survivors often have a limitation
168298
NEW treatment regime offers hope to cancer patients
14343
Stress may increase risk for cancer
95241
Common cancer drugs may offer treatment for type 1 diabetes
9918
Curcumin may delay liver damage, cirrhosis
69828
Higher levels of vitamin B6 reduce the risk for lung cancer